Papillary Thyroid Cancer and Central Lymp Node Dissection

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

March 24, 2023

Conditions
Papillary Thyroid Cancer
Trial Locations (1)

Unknown

BasaksehirCamSakuraSehirH, Istanbul

All Listed Sponsors
lead

Başakşehir Çam & Sakura City Hospital

OTHER_GOV

NCT05873283 - Papillary Thyroid Cancer and Central Lymp Node Dissection | Biotech Hunter | Biotech Hunter